BofA on Progyny (PGNY): 'Positive 4Q preannouncement reflects execution and recent momentum'

January 12, 2026 9:23 AM EST Send to a Friend
BofA Securities analyst Allen Lutz reiterated a Buy rating and $30.00 price target on Progyny (NASDAQ: PGNY).The analyst comments "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login